Brief: Australian Clinical Labs Announces FY2026 Interim Dividend Of 3.75 AU CPS
Feb 16 (Reuters) - Australian Clinical Labs Ltd ACL.AX: FY2026 INTERIM DIVIDEND 3.75 AU CPS H1 NET INCOME AUD 5.6 MILLION H1 REVENUE AUD 365.4 MILLION Further company coverage: ACL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million